A Pseudo-False Negative Urine Methadone Screen in a Patient Treated With Rifampin

Abstract

Get full access to this article

View all access options for this article.

References

Volpe

Sahajwalla

Younis

Patel

Methadone metabolism and drug-drug interactions: in vitro and in vivo literature review. J Pharm Sci. 2018;107:2983-2991. doi:10.1016/j.xphs.2018.08.025

Ferrari

Coccia

CPR

Bertolini

Sternieri

Methadone—metabolism, pharmacokinetics and interactions. Pharmacol Res. 2004;50:551-559. doi:10.1016/j.phrs.2004.05.002

Lee

Lewis

Tsongalis

et al. Negative urine opioid screening caused by rifampin-mediated induction of oxycodone hepatic metabolism. Clin Chim Acta. 2006;367:196-200. doi:10.1016/j.cca.2005.11.030

Kreek

Garfield

Gutjahr

Giusti

LM.

Rifampin-induced methadone withdrawal. N Engl J Med. 1976;294:1104-1106.

Horn

Hansten

Chan

LN.

Proposal for a new tool to evaluate drug interaction cases. Ann Pharmacother. 2007;41:674-680. doi:10.1345/aph.1H423

Yamashita

Sasa

Yoshida

et al. Modeling of rifampicin-induced CYP3A4 activation dynamics for the prediction of clinical drug-drug interactions from in vitro data. PLoS One. 2013;8:e70330. doi:10.1371/journal.pone.0070330